Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation.

Michels AW, Ostrov DA, Zhang L, Nakayama M, Fuse M, McDaniel K, Roep BO, Gottlieb PA, Atkinson MA, Eisenbarth GS.

J Immunol. 2011 Dec 1;187(11):5921-30. doi: 10.4049/jimmunol.1100746. Epub 2011 Oct 31.

2.

A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.

Gregori S, Trembleau S, Penna G, Gallazzi F, Hammer J, Papadopoulos GK, Adorini L.

J Immunol. 1999 Jun 1;162(11):6630-40.

4.

Antigen presentation in the autoimmune diabetes of the NOD mouse.

Unanue ER.

Annu Rev Immunol. 2014;32:579-608. doi: 10.1146/annurev-immunol-032712-095941. Epub 2014 Feb 5. Review.

PMID:
24499272
5.
7.

Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.

Lee KH, Wucherpfennig KW, Wiley DC.

Nat Immunol. 2001 Jun;2(6):501-7. Erratum in: Nat Immunol 2001 Sep;2(9):889.

PMID:
11376336
9.

Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.

Liu J, Purdy LE, Rabinovitch S, Jevnikar AM, Elliott JF.

Diabetes. 1999 Mar;48(3):469-77.

PMID:
10078545
10.

The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.

Chao CC, Sytwu HK, Chen EL, Toma J, McDevitt HO.

Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9299-304. Erratum in: Proc Natl Acad Sci U S A 1999 Oct 26;96(22):12970.

11.

MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.

Kupfer TM, Crawford ML, Pham K, Gill RG.

J Immunol. 2005 Aug 15;175(4):2309-16.

12.

HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.

Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC.

J Immunol. 2004 Mar 15;172(6):3955-62.

13.

Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice.

Zhang L, Stadinski BD, Michels A, Kappler JW, Eisenbarth GS.

Diabetes Metab Res Rev. 2011 Nov;27(8):784-9. doi: 10.1002/dmrr.1252.

PMID:
22069260
14.

Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.

Masteller EL, Warner MR, Ferlin W, Judkowski V, Wilson D, Glaichenhaus N, Bluestone JA.

J Immunol. 2003 Nov 15;171(10):5587-95.

16.

T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.

Morkowski S, Goldrath AW, Eastman S, Ramachandra L, Freed DC, Whiteley P, Rudensky AYu.

J Exp Med. 1995 Nov 1;182(5):1403-13.

17.

MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.

Serreze DV, Holl TM, Marron MP, Graser RT, Johnson EA, Choisy-Rossi C, Slattery RM, Lieberman SM, DiLorenzo TP.

J Immunol. 2004 Jan 15;172(2):871-9.

18.

Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.

Ranheim EA, Tarbell KV, Krogsgaard M, Mallet-Designe V, Teyton L, McDevitt HO, Weissman IL.

Autoimmunity. 2004 Dec;37(8):555-67.

PMID:
15763918
19.

Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.

Dahan R, Gebe JA, Preisinger A, James EA, Tendler M, Nepom GT, Reiter Y.

J Autoimmun. 2013 Dec;47:83-93. doi: 10.1016/j.jaut.2013.08.009. Epub 2013 Oct 3.

PMID:
24090977
20.

Supplemental Content

Support Center